Defunct Company
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
90
NCT00042497
Immunotherapy With Autologous Dexosomes for Patients With Stage IV Melanoma
Phase: Phase 2
Role: Lead Sponsor
Start: Jul 31, 2002
Completion: Not specified
NCT04621968
Correlations Between Nutrition and Urine Spot Checks Via a Urinary Self-test
Phase: N/A
Start: Dec 31, 2020
Completion: Oct 31, 2021